|
Homepage
Tables of Contents
Features
Real Life Stories
Poetry
Fiction
FYI
Theme
Other Monthly
Related Links
Who's in Issue
Awards
Ahead to
Feb.
Guestbook
Archives
Gallery
Please Visit
The World
of MS MuSings
| |

From Gaz, Garry
Starr
Christmas Issue 2003
This publication is for those who have MS, those who care for
that wonderful group of people who have MS and for anyone interested in helping
those with MS. We welcome Msers, carers, medical professionals and anyone who
has the time to share with us.
The names of those group members who are willing to accept Phone
contact are listed below.
Garry Starr 6342 3094
Pauline Taylor 6345 2247
Carol Brennan 6341 3170
Delia Thomson 6367 5015
Dulcie Maybury 6341 1686
Janet Freebairn 6342 2141
June& Kevin Sheedy
6345 3449
Kerri Webb 6345 1926
Margaret Cooke 6342 5367
Ross McDonald 6862 5545
Peter &Jenny Mould
63424969
APOLOGY
I
am sorry that I have not had time to spend organising our group meetings. The
Tidy Towns State Awards weekend tended to take over everything. The weekend went
well so I guess the work was worth it for Cowra. Garry Starr
Xmas
Dinner
I have booked the restaurant at the Cowra Bowling Club for next
Thursday 18th December 7.00pm for our Christmas dinner. I rang most
of our local members and it should be a good night. Please let me know if you
can’t make it.
A ‘New’ Treatment for MS ?
Recently I have become aware of a treatment
for MS which uses the drug Naltrexone. Naltrexone is a drug that is usually
used to take away the addictiveness of such drugs as heroin. The drug was first
tried in 1985 by a Dr Bihari in NewYork on the daughter of a colleague who had
been diagnosed with MS at a young age. This is a drug that seems to be helping
many people with MS though it is still regarded as somewhat experimental by
some. Naltrexone (Low Dose
Naltrexone)
The following explains
Low Dose Naltrexone (also known as LDN) from a layperson's perspective that
everyone should be able to understand. Please note that we are not medical
doctors, and that there is no formal proof of the following statements; they are
merely informed hypotheses. You should always do your own research and consult
with your doctor before undertaking any medical treatment Naltrexone is
an FDA approved drug (1984) that was originally intended to treat people
suffering from opium (e.g., heroin) addiction. It treated these addictions by
blocking the "pleasant" effects from the drug, so addicts who took it did not
get "high" anymore.
How does it block the "high?" There are receptors in our brain that an opioid
like heroin would use to get into the cell and do its deed. Naltrexone blocks
those receptors, so the heroin can't have an effect. Think about it like a
puzzle piece-- some brain cells have a piece that accepts opium and its
derivatives, and the Naltrexone simply matches that piece. When the heroin
floats around, it has no where to go.
OK, that's all well and good, but what relevance is there to Multiple Sclerosis?
Well, those opiod receptors in our brains are not JUST for receiving drugs like
heroin-- our bodies actually produce opiods every day, among other things, we
produce a set of hormones called endorphins. So if you were to take Naltrexone,
you would actually block the reception of something your body produces. These
hormones, as it turns out, play a very important part in controlling the immune
system. Keep this in mind for what we'll talk about below.
The FDA-approved dosage for heroin addicts was 50 milligrams per day. This
ensured that those receptors were blocked all day and there was no chance that
any heroin could connect with a cell and give the user a "high."
BUT a medical doctor named Dr. Bihari found that if you give someone a much
lower dose, say THREE milligrams instead of 50, you would not block the
receptors all day, but just for a couple of hours. After that, everything would
function as normal.
But the human body is funny-- when you block something, it often responds by
producing more. In other words, if you were to take Naltrexone at a low dose
(Low Dose Naltrexone, even!) you would block the receptors for a couple hours.
The body would notice that it was not receiving the endorphins it produced, so
it would think "Since they're not getting through, I must not be producing
enough-- turn it up!" The gland responsible for producing the endorphins, called
the pituitary, would respond by producing significantly more. Not enough to
cause any problems, but enough to make a difference.
So how
can this all matter for Multiple Sclerosis? Remember how we discussed above that
the endorphins actually regulate the immune system? Well, in Multiple Sclerosis,
the immune system is malfunctioning-- it's attacking it's own body. Anything
that helps regulate, control, and tame the immune system could potentially have
a positive effect on MS. And that's exactly what some people who take LDN
report-- a halt of the progression of the disease, and even some improvement in
symptoms.
Adding some scientific validity are studies that show that in MS patients, the
pituitary gland (which produces endorphins) shrinks as the disease progresses.
This shrinkage can be assumed to correspond with less endorphin production,
though the link is not concrete. The million dollar question is: is the
pituitary gland shrinking BECAUSE of the MS, in which case fixing the pituitary
is more like treating a symptom rather than the cause, OR is the pituitary
smaller in people who have multiple sclerosis and could potentially be a, if not
the, cause of the disease in the first place? In other words, is a shrunken
pituitary a cause of MS or is it an effect? If it's a cause, making up for the
lower endorphin output by taking something like LDN could have significant
positive implications.
There is a catch to all of this-- there are no formal, clinical trials on taking
low dose naltrexone for multiple sclerosis (though one just got underway for
Crohn's disease and Crohn's is an autoimmune disorder like MS). All there is,
is speculation, a few doctors backing it, and most remarkably, many positive
testimonials from patients.
This
article came from the following source.
http://www.thisisms.com This is
an MS Unbiased Multiple Sclerosis Community
This is NOT a cure
but may well be a viable treatment.
Two
friends and I have begun this treatment. We all come from country NSW and have
had MS for some years. We have all noted improvements in our symptoms and we
will try to keep you posted as to how we fare in the future. Garry
Have you ever heard of
Hughes Syndrome?
Hughes syndrome,
also known as antiphospholipid syndrome or 'sticky blood' is a disorder
characterized by blood clotting, both in the
arteries and veins.
Some of the symptoms mimic those of MS.
Another way in which the brain reacts to ‘sticky blood’ is with
odd features such as pins and needles, balance disorder and giddiness, visual
disturbances (such as loss of part of the field of vision) and so on. One of the
main alternative diagnoses in patients with the syndrome is multiple sclerosis,
and it came as no surprise to our clinical team that a number of our patients
had been previously diagnosed with “multiple sclerosis”.
Hughes syndrome
is caused by the presence of
antibodies in the blood, called antiphospholipid antibodies. These
antibodies make the
immune system work too hard, increasing blood clotting. Blood
clotting can affect anyone of any age and can happen suddenly e.g. leg
thrombosis or over a number of years.
Source: Hughes
Syndrome Home Page.
http://www.homehealth-uk.com/medical/hughessyndrome.htm
HAPPY CHRISTMAS TO ALL AND A HAPPY NEWYEAR!
Contact Garry Starr
starrgh@tpg.com.au
Meet Gaz in our
Gallery!
top of
page
| |
|